APOE genotyping and response to drug treatment in Alzheimer's disease

Lancet. 1997 Feb 22;349(9051):539. doi: 10.1016/S0140-6736(97)80089-X.
No abstract available

Publication types

  • Clinical Trial
  • Clinical Trial, Phase II
  • Letter
  • Multicenter Study
  • Randomized Controlled Trial

MeSH terms

  • Alzheimer Disease / drug therapy*
  • Apolipoproteins E / genetics*
  • Genotype
  • Humans
  • Mental Status Schedule
  • Morpholines / therapeutic use*
  • Quinolines / therapeutic use*

Substances

  • Apolipoproteins E
  • Morpholines
  • Quinolines
  • S 12024